A study by researchers from Yale University and Brown University suggests that low-to-moderate alcohol consumption during pregnancy may not increase risk of birth outcomes such as low birthweight.
A study by researchers from Yale University and Brown University suggests that low-to-moderate alcohol consumption during pregnancy may not increase risk of birth outcomes such as low birthweight. The findings, from an epidemiologic study, were published in the Annals of Epidemiology and reflect associations, not direct cause and effect.
Researchers used multivariate analysis to estimate whether low-to-moderate prenatal alcohol exposure was associated with selected birth outcomes in a cohort of 4,496 women with singleton infants. The outcomes evaluated were low birthweight, preterm delivery, intrauterine growth restriction (IUGR), and selected perinatal outcomes.
Resident's blog: Is there a doctor on board?
Odds of low birthweight and of birth length less than 10th percentile were reduced in offspring of women who drank in early pregnancy (OR 0.66; 95% CI, 0.46-0.96 and OR 0.75; 95% CI, 0.56-0.97, respectively). Reduced odds of birth length and head circumferences less than 10th percentile were associated with drinking during the first trimester (OR 0.56; 95% CI, 0.36-0.87 and OR 0.69; 95% CI, 0.50-0.96, respectively). Drinking during the third trimester was associated with lower odds of low birthweight and preterm delivery (OR 0.56; 95% CI, 0.34-0.94 and OR 0.60; 95% CI, 0.42-0.87, respectively).
The researchers concluded that low-to-moderate alcohol exposure during early and late gestation is not associated with increased risk of low birthweight, preterm delivery, IUGR, and most selected perinatal outcomes.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary OB/GYN Special Delivery.
Link between reproductive life span and postmenopausal muscle mass
November 30th 2023A recent study in Menopause, the journal of The Menopause Society, suggests that a longer reproductive life span and later age at menopause may be associated with a reduced risk of low handgrip strength in postmenopausal women.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
How physicians can boost COVID-19 vaccine uptake among Spanish-speaking pregnant individuals
November 29th 2023Discover the crucial findings from a recent study investigating vaccine decision-making among Spanish-speaking pregnant individuals, highlighting the pivotal role doctors play in dispelling vaccine hesitancy and fostering acceptance through targeted information dissemination and culturally sensitive approaches.
Read More
Inactivated COVID-19 vaccines in pregnancy: No impact on neonatal outcome, study finds
November 28th 2023A comprehensive cohort study explored the impact of inactivated COVID-19 vaccines administered within 3 months before conception, revealing reassuring findings that neonatal outcomes, including preterm birth and NICU admission, remain unaffected.
Read More